Annual Cash & Cash Equivalents
$4.01 B
-$4.07 B-50.37%
December 31, 2024
Summary
- As of February 28, 2025, TMO annual cash & cash equivalents is $4.01 billion, with the most recent change of -$4.07 billion (-50.37%) on December 31, 2024.
- During the last 3 years, TMO annual cash & cash equivalents has fallen by -$468.00 million (-10.45%).
- TMO annual cash & cash equivalents is now -61.17% below its all-time high of $10.32 billion, reached on December 31, 2020.
Performance
TMO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.01 B
-$636.00 M-13.69%
December 31, 2024
Summary
- As of February 28, 2025, TMO quarterly cash and cash equivalents is $4.01 billion, with the most recent change of -$636.00 million (-13.69%) on December 31, 2024.
- Over the past year, TMO quarterly cash and cash equivalents has dropped by -$4.07 billion (-50.37%).
- TMO quarterly cash and cash equivalents is now -66.67% below its all-time high of $12.03 billion, reached on September 1, 2021.
Performance
TMO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TMO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.4% | -50.4% |
| 3 y3 years | -10.4% | -50.4% |
| 5 y5 years | +67.1% | -50.4% |
TMO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.0% | at low | -53.0% | +112.3% |
| 5 y | 5-year | -61.2% | +67.1% | -66.7% | +112.3% |
| alltime | all time | -61.2% | >+9999.0% | -66.7% | >+9999.0% |
Thermo Fisher Scientific Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.01 B(-50.4%) | $4.01 B(-13.7%) |
| Sep 2024 | - | $4.64 B(-34.3%) |
| Jun 2024 | - | $7.07 B(+28.6%) |
| Mar 2024 | - | $5.50 B(-31.9%) |
| Dec 2023 | $8.08 B(-5.2%) | $8.08 B(+31.3%) |
| Sep 2023 | - | $6.15 B(+96.3%) |
| Jun 2023 | - | $3.13 B(-10.0%) |
| Mar 2023 | - | $3.48 B(-59.2%) |
| Dec 2022 | $8.52 B(+90.4%) | $8.52 B(+192.0%) |
| Sep 2022 | - | $2.92 B(+54.6%) |
| Jun 2022 | - | $1.89 B(-31.4%) |
| Mar 2022 | - | $2.75 B(-38.5%) |
| Dec 2021 | $4.48 B(-56.6%) | $4.48 B(-62.8%) |
| Sep 2021 | - | $12.03 B(+71.3%) |
| Jun 2021 | - | $7.02 B(+25.8%) |
| Mar 2021 | - | $5.58 B(-45.9%) |
| Dec 2020 | $10.32 B(+330.4%) | $10.32 B(+36.9%) |
| Sep 2020 | - | $7.54 B(+29.6%) |
| Jun 2020 | - | $5.82 B(+95.2%) |
| Mar 2020 | - | $2.98 B(+24.3%) |
| Dec 2019 | $2.40 B(+14.1%) | $2.40 B(+88.5%) |
| Sep 2019 | - | $1.27 B(-44.4%) |
| Jun 2019 | - | $2.29 B(+106.9%) |
| Mar 2019 | - | $1.11 B(-47.4%) |
| Dec 2018 | $2.10 B(+57.5%) | $2.10 B(+91.5%) |
| Sep 2018 | - | $1.10 B(+17.2%) |
| Jun 2018 | - | $937.00 M(-1.4%) |
| Mar 2018 | - | $950.00 M(-28.8%) |
| Dec 2017 | $1.33 B(+69.8%) | $1.33 B(+80.1%) |
| Sep 2017 | - | $741.10 M(+21.3%) |
| Jun 2017 | - | $611.00 M(-14.3%) |
| Mar 2017 | - | $713.30 M(-9.2%) |
| Dec 2016 | $786.00 M(+73.9%) | $786.00 M(-60.1%) |
| Sep 2016 | - | $1.97 B(+197.1%) |
| Jun 2016 | - | $663.10 M(-19.8%) |
| Mar 2016 | - | $826.80 M(+82.9%) |
| Dec 2015 | $452.10 M(-66.3%) | $452.10 M(-10.2%) |
| Sep 2015 | - | $503.40 M(-34.5%) |
| Jun 2015 | - | $768.40 M(-11.1%) |
| Mar 2015 | - | $864.60 M(-35.6%) |
| Dec 2014 | $1.34 B(-76.9%) | $1.34 B(+151.5%) |
| Sep 2014 | - | $534.30 M(-8.7%) |
| Jun 2014 | - | $584.90 M(-60.9%) |
| Mar 2014 | - | $1.50 B(-74.3%) |
| Dec 2013 | $5.83 B(+623.2%) | $5.83 B(+215.7%) |
| Sep 2013 | - | $1.85 B(+31.0%) |
| Jun 2013 | - | $1.41 B(+40.3%) |
| Mar 2013 | - | $1.00 B(+24.6%) |
| Dec 2012 | $805.60 M(-20.7%) | $805.60 M(-3.2%) |
| Sep 2012 | - | $832.20 M(+13.6%) |
| Jun 2012 | - | $732.30 M(-7.1%) |
| Mar 2012 | - | $788.30 M(-22.4%) |
| Dec 2011 | $1.02 B(+10.8%) | $1.02 B(+14.2%) |
| Sep 2011 | - | $890.30 M(-34.3%) |
| Jun 2011 | - | $1.36 B(-51.4%) |
| Mar 2011 | - | $2.79 B(+204.1%) |
| Dec 2010 | $917.10 M(-41.4%) | $917.10 M(-29.9%) |
| Jun 2010 | - | $1.31 B(-8.7%) |
| Mar 2010 | - | $1.43 B(-8.5%) |
| Dec 2009 | $1.56 B(+22.1%) | $1.56 B(-10.4%) |
| Sep 2009 | - | $1.75 B(+23.2%) |
| Jun 2009 | - | $1.42 B(-9.2%) |
| Mar 2009 | - | $1.56 B(+21.9%) |
| Dec 2008 | $1.28 B(+104.8%) | $1.28 B(+3.2%) |
| Sep 2008 | - | $1.24 B(+23.2%) |
| Jun 2008 | - | $1.01 B(+37.2%) |
| Mar 2008 | - | $734.00 M(+17.4%) |
| Dec 2007 | $625.10 M(-6.3%) | $625.10 M(-24.8%) |
| Sep 2007 | - | $830.80 M(-12.7%) |
| Jun 2007 | - | $951.20 M(+41.8%) |
| Mar 2007 | - | $670.90 M(+0.5%) |
| Dec 2006 | $667.40 M | $667.40 M(+322.5%) |
| Sep 2006 | - | $157.96 M(-16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $189.72 M(-17.8%) |
| Mar 2006 | - | $230.79 M(+7.7%) |
| Dec 2005 | $214.33 M(-34.4%) | $214.33 M(+10.8%) |
| Sep 2005 | - | $193.46 M(+21.1%) |
| Jun 2005 | - | $159.74 M(-54.6%) |
| Mar 2005 | - | $351.56 M(+7.5%) |
| Dec 2004 | $326.89 M(+67.0%) | $326.89 M(-2.6%) |
| Sep 2004 | - | $335.66 M(+9.5%) |
| Jun 2004 | - | $306.62 M(-13.1%) |
| Mar 2004 | - | $352.99 M(+80.3%) |
| Dec 2003 | $195.77 M(-42.3%) | $195.77 M(-5.7%) |
| Sep 2003 | - | $207.55 M(-21.5%) |
| Jun 2003 | - | $264.44 M(+6.2%) |
| Mar 2003 | - | $249.11 M(-26.5%) |
| Dec 2002 | $339.04 M(+13.9%) | $339.04 M(+45.1%) |
| Sep 2002 | - | $233.60 M(-0.6%) |
| Jun 2002 | - | $234.91 M(-25.4%) |
| Mar 2002 | - | $315.00 M(+5.9%) |
| Dec 2001 | $297.56 M(-41.1%) | $297.56 M(-12.5%) |
| Sep 2001 | - | $340.19 M(-32.8%) |
| Jun 2001 | - | $506.35 M(+56.1%) |
| Mar 2001 | - | $324.40 M(-35.8%) |
| Dec 2000 | $505.52 M(+79.4%) | $505.52 M(+57.5%) |
| Sep 2000 | - | $320.96 M(+14.1%) |
| Jun 2000 | - | $281.17 M(-47.3%) |
| Mar 2000 | - | $533.47 M(+89.3%) |
| Dec 1999 | $281.80 M(+5.0%) | $281.80 M(-33.6%) |
| Sep 1999 | - | $424.30 M(+9.7%) |
| Jun 1999 | - | $386.90 M(-4.3%) |
| Mar 1999 | - | $404.20 M(+50.7%) |
| Dec 1998 | $268.30 M(-54.8%) | $268.30 M(-35.5%) |
| Sep 1998 | - | $416.10 M(-31.9%) |
| Jun 1998 | - | $611.00 M(+2.6%) |
| Mar 1998 | - | $595.70 M(+0.4%) |
| Dec 1997 | $593.60 M(+43.2%) | $593.60 M(+20.3%) |
| Sep 1997 | - | $493.30 M(+70.9%) |
| Jun 1997 | - | $288.70 M(-15.5%) |
| Mar 1997 | - | $341.80 M(-17.5%) |
| Dec 1996 | $414.40 M(-10.3%) | $414.40 M(-18.2%) |
| Sep 1996 | - | $506.50 M(-6.4%) |
| Jun 1996 | - | $541.20 M(-30.1%) |
| Mar 1996 | - | $774.70 M(+67.7%) |
| Dec 1995 | $462.00 M(+20.7%) | $462.00 M(+4.6%) |
| Sep 1995 | - | $441.60 M(-16.5%) |
| Jun 1995 | - | $528.90 M(+30.2%) |
| Mar 1995 | - | $406.30 M(+6.1%) |
| Dec 1994 | $382.80 M(+17.5%) | $382.80 M(+24.6%) |
| Sep 1994 | - | $307.20 M(+6.0%) |
| Jun 1994 | - | $289.70 M(+12.5%) |
| Mar 1994 | - | $257.60 M(-20.9%) |
| Dec 1993 | $325.70 M(+70.9%) | $325.70 M(-5.8%) |
| Sep 1993 | - | $345.60 M(+325.1%) |
| Jun 1993 | - | $81.30 M(-24.3%) |
| Mar 1993 | - | $107.40 M(-43.7%) |
| Dec 1992 | $190.60 M(+45.5%) | $190.60 M(+14.7%) |
| Sep 1992 | - | $166.20 M(+22.7%) |
| Jun 1992 | - | $135.50 M(-7.5%) |
| Mar 1992 | - | $146.50 M(+11.8%) |
| Dec 1991 | $131.00 M(+11.1%) | $131.00 M(+18.1%) |
| Sep 1991 | - | $110.90 M(+1.2%) |
| Jun 1991 | - | $109.60 M(-19.0%) |
| Mar 1991 | - | $135.30 M(+14.8%) |
| Dec 1990 | $117.90 M(+25.6%) | $117.90 M(+40.0%) |
| Sep 1990 | - | $84.20 M(+68.7%) |
| Jun 1990 | - | $49.90 M(-27.9%) |
| Mar 1990 | - | $69.20 M(-26.3%) |
| Dec 1989 | $93.90 M(-31.2%) | $93.90 M(+45.4%) |
| Sep 1989 | - | $64.60 M(-52.6%) |
| Dec 1988 | $136.40 M(-5.3%) | $136.40 M(-5.3%) |
| Dec 1987 | $144.10 M(+125.9%) | $144.10 M(+125.9%) |
| Dec 1986 | $63.80 M(+112.7%) | $63.80 M(+112.7%) |
| Dec 1985 | $30.00 M(+163.2%) | $30.00 M(+163.2%) |
| Dec 1984 | $11.40 M | $11.40 M |
FAQ
- What is Thermo Fisher Scientific annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific annual cash & cash equivalents year-on-year change?
- What is Thermo Fisher Scientific quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific quarterly cash and cash equivalents year-on-year change?
What is Thermo Fisher Scientific annual cash & cash equivalents?
The current annual cash & cash equivalents of TMO is $4.01 B
What is the all time high annual cash & cash equivalents for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high annual cash & cash equivalents is $10.32 B
What is Thermo Fisher Scientific annual cash & cash equivalents year-on-year change?
Over the past year, TMO annual cash & cash equivalents has changed by -$4.07 B (-50.37%)
What is Thermo Fisher Scientific quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TMO is $4.01 B
What is the all time high quarterly cash and cash equivalents for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high quarterly cash and cash equivalents is $12.03 B
What is Thermo Fisher Scientific quarterly cash and cash equivalents year-on-year change?
Over the past year, TMO quarterly cash and cash equivalents has changed by -$4.07 B (-50.37%)